Publication:
Eleven-year experience on anti-TB drugs direct susceptibility testing from Siriraj Hospital, Thailand

dc.contributor.authorAngkana Chaipraserten_US
dc.contributor.authorSomboon Srimuangen_US
dc.contributor.authorNipa Tingtoyen_US
dc.contributor.authorNampueng Makhaoen_US
dc.contributor.authorParach Sirirudeepornen_US
dc.contributor.authorNongnard Tomnongdeeen_US
dc.contributor.authorOrathai Theankeawen_US
dc.contributor.authorSukanya Charoensooken_US
dc.contributor.authorManoon Leechawengwongsen_US
dc.contributor.authorTherdsak Prammanananen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherVichaiyut Hospitalen_US
dc.contributor.otherThailand National Center for Genetic Engineering and Biotechnologyen_US
dc.date.accessioned2018-10-19T05:12:58Z
dc.date.available2018-10-19T05:12:58Z
dc.date.issued2013-11-01en_US
dc.description.abstractThe early detection of drug-resistant tuberculosis (TB) strains is of utmost importance for patient management and effective TB control programs. This study aimed to demonstrate the performance of direct drug susceptibility testing (DST) performed in our laboratory in the past 11 years. The direct DST was performed on Middlebrook 7H10 medium using isoniazid (INH) and rifampicin (RIF), and the results were compared with those obtained from indirect DST (gold standard). The direct DST was performed with 15,598 smear-positive sputum samples, of which 11,284 (72%) yielded reportable results. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated and revealed 89%, 99%, 95%, and 99%, respectively, for RIF and 90%, 98%, 93%, and 97%, respectively, for INH. Direct DST results could be reported within 1 month after sample processing. This method was also shown to be suitable for use in resource-limited countries, particularly in settings with high numbers of TB cases. © 2013 Elsevier Inc.en_US
dc.identifier.citationDiagnostic Microbiology and Infectious Disease. Vol.77, No.3 (2013), 241-244en_US
dc.identifier.doi10.1016/j.diagmicrobio.2013.06.029en_US
dc.identifier.issn18790070en_US
dc.identifier.issn07328893en_US
dc.identifier.other2-s2.0-84885388492en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/32094
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84885388492&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleEleven-year experience on anti-TB drugs direct susceptibility testing from Siriraj Hospital, Thailanden_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84885388492&origin=inwarden_US

Files

Collections